4 active trials 4 recruiting 1 disease areas
| Early Phase 1 | 1 | |
| Phase 1 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06115135 | A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for… | Multiple Myeloma in Relapse | Recruiting | 2025-01-16 |
| Phase 1 | ||||
| NCT06225310 | A Trial of Selinexor, Ruxolitinib and Methylprednisolone | Multiple Myeloma in Relapse | Recruiting | 2025-01-16 |
| NCT03110822 | A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory… | Multiple Myeloma | Recruiting | 2023-11-01 |
| Early Phase 1 | ||||
| NCT06209606 | Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple… | Multiple Myeloma | Recruiting | 2024-12-17 |
Multiple Myeloma (4)